Bertolini, Federico http://orcid.org/0000-0003-0936-2908
Ostuzzi, Giovanni
Pievani, Michela
Aguglia, Andrea
Bartoli, Francesco
Bortolaso, Paola
Callegari, Camilla
Caroleo, Mariarita
Carrà, Giuseppe
Corbo, Mariangela
D’Agostino, Armando
De Fazio, Pasquale
Magliocco, Fabio
Martinotti, Giovanni
Ostinelli, Edoardo Giuseppe
Piccinelli, Marco Piero
Tedeschi, Federico
Barbui, Corrado
,
Funding for this research was provided by:
Università degli Studi di Verona
Article History
Accepted: 17 March 2021
First Online: 29 March 2021
Declarations
:
: Open access funding provided by Università degli Studi di Verona within the CRUI-CARE Agreement.
: Giovanni Martinotti has been a consultant and/or a speaker and/or has received research grants from Angelini, Doc Generici, Janssen, Lundbeck, Otsuka, and Pfizer. Federico Bertolini, Giovanni Ostuzzi, Michela Pievani, Andrea Aguglia, Francesco Bartoli, Paola Bortolaso, Camilla Callegari, Mariarita Caroleo, Giuseppe Carrà, Mariangela Corbo, Armando D’Agostino, Pasquale De Fazio, Fabio Magliocco, Edoardo Giuseppe Ostinelli, Marco Piero Piccinelli, Federico Tedeschi and Corrado Barbui have no conflicts of interest that are directly relevant to the content of this article.
: The study dataset is available from the authors on reasonable request.
: The study protocol was approved by the local ethics committee of the coordinating centre (Ethics Committee for Clinical Trials of the Provinces of Verona and Rovigo, protocol n. 57622 of the 09/12/2015) and of each participating centre.
: Participants provided written consent to data collection.
: Not applicable.
: GO, GC, GM and CB contributed to study design. GO, FT and CB conducted the statistical analysis. All authors contributed to interpretation of the data. FB, GO and CB wrote the manuscript. All authors reviewed and commented on manuscript drafts and approved the final article and the decision to submit it for publication.